Skip to content

Axon iOS

by Exsurgo Limited

Axon iOS (100318) is a psychophysiological biofeedback system (FDA Class II; FDA product code HCC, Device, Biofeedback) made by Exsurgo Limited, listed in FDA GUDID since 15 Jan 2025 (UDI-DI 09413000107500), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number09413000107500 UDI-DI Date15 Jan 2025ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Axon Neurofeedback software Application for iOS
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Axon
Generic name
Psychophysiological biofeedback system
Model / Ref / Catalog
iOS, 100318
Primary DI / UDI-DI
09413000107500
FDA product code
HCC
GMDN term
Psychophysiological biofeedback system
Device class
Class II
Regulation number
882.5050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Psychophysiological biofeedback system.

Other devices from Exsurgo Limited

Properties

  • Prescription use
  • Premarket exempt
  • Lot / batch number
Other properties (12, all answered No)